Viatris Inc. logo

Viatris Inc. (VTRS)

Health Care
$17.29
-0.23%

1 article

Price chart

+16.3%Apr 20 – Jul 17
$14.52$15.95$17.39Apr 20May 18Jun 17Jul 17
Hover the chart for daily prices

Viatris Inc. (VTRS) overview

Viatris is a generic and specialty pharmaceutical company. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.

Viatris Inc. trades on the NasdaqGS under the ticker symbol VTRS. As of the most recent market data, the stock was priced around $17.29, down 0.23% on the session, giving Viatris Inc. a market capitalization of roughly $20.14B.

Over the past 52 weeks, VTRS has traded between $8.63 and $17.67. Viatris Inc. also pays a dividend, currently yielding around 2.78%.

Key statistics

Price
$17.29
Change (1d)
-0.23%
Market cap
$20.14B
52-week range
$8.63 – $17.67
Day range
$17.23 – $17.67
Volume
9.4M
Dividend yield
2.78%

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.

Why investors watch VTRS

As one of the larger companies in the Health Care sector, Viatris Inc. is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch VTRS for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.

Market Mood

1 Bullish0 Neutral0 Bearish

Latest VTRS news

IHE vs IXJ: 39.7% vs 10% 1-Year Returns in ETFs Comparison
MarketsBullish5/27/2026

IHE vs IXJ: 39.7% vs 10% 1-Year Returns in ETFs Comparison

The iShares U.S. Pharmaceuticals ETF (IHE) has posted a 1-year return of 39.70% as of May 20, 2026, while the iShares Global Healthcare ETF (IXJ) reported a return of 10.00%. Both funds have similar expense ratios, with IHE at 0.38% and IXJ at 0.40%. IHE's assets under management (AUM) stand at $883.6 million, compared to IXJ's $3.6 billion. Additionally, IHE has a higher dividend yield of 1.70% versus IXJ's 1.50%, indicating potential advantages for investors favoring domestic pharmaceutical exposure.

Read More: IHE vs IXJ: 39.7% vs 10% 1-Year Returns in ETFs Comparison

More Health Care stocks

Frequently asked questions

Is Viatris Inc. in the S&P 500?

Yes. Viatris Inc. (VTRS) is a member of the S&P 500 index, classified in the Health Care sector.

What sector is VTRS in?

Viatris Inc. is classified in the Health Care sector of the S&P 500 — pharmaceutical, biotech, device and managed-care companies.

Where can I find the latest VTRS news?

This page collects recent Viatris Inc. (VTRS) news and market analysis, each article summarized by AI and tagged with bullish, bearish, or neutral sentiment.

What is Viatris Inc.'s stock price?

As of the most recent market data, Viatris Inc. (VTRS) traded at approximately $17.29. Prices move throughout the trading day, so this reflects the latest available quote rather than a live price.

What is Viatris Inc.'s market cap?

Viatris Inc. has a market capitalization of roughly $20.14B, based on its most recent share price and shares outstanding.

New to investing?